Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

2022 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 2022 ;2022 by the American Diabetes Association 2022 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc21-1815 ;PMID: 35015080

Full text available

Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease—Perspective from the Veterans Affair Healthcare System

Springer Science+Business Media, LLC, part of Springer Nature 2021 ;2021. Springer Science+Business Media, LLC, part of Springer Nature. ;Springer Science+Business Media, LLC, part of Springer Nature 2021. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-021-07148-4 ;PMID: 33523335

Full text available

MULTINATIONAL PATTERNS OF SECOND-LINE ANTI-HYPERGLYCEMIC DRUG INITIATION IN ESTABLISHED CARDIOVASCULAR DISEASE: A FEDERATED PHARMACOEPIDEMIOLOGIC EVALUATION IN LEGEND-T2DM

2023 American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(23)02090-9

Full text available

FACILITY LEVEL VARIATION IN THE REPORTING OF STATIN-ASSOCIATED SIDE EFFECTS AMONG PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

2021 American College of Cardiology Foundation ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(21)02867-9

Full text available

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease

2021 ;ISSN: 2666-6677 ;EISSN: 2666-6677 ;DOI: 10.1016/j.ajpc.2021.100300 ;PMID: 34950914

Full text available

Evaluation of intervertebral body implant performance using active surveillance of electronic health records

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2631-4940 ;EISSN: 2631-4940 ;DOI: 10.1136/bmjsit-2021-000125 ;PMID: 35909993

Full text available

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM

Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;EISSN: 2754-0413 ;DOI: 10.1136/bmjmed-2023-000651 ;PMID: 37829182

Full text available

High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study

COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;The Author(s). 2016 ;ISSN: 1471-2369 ;EISSN: 1471-2369 ;DOI: 10.1186/s12882-016-0411-7 ;PMID: 27881100

Full text available

Multinational Patterns of Second-line Anti-hyperglycemic Drug Initiation Across Cardiovascular Risk Groups: A Federated Pharmacoepidemiologic Evaluation in LEGEND-T2DM

Digital Resources/Online E-Resources

Validating an automated outcomes surveillance application using data from a terminated randomized, controlled trial (OPUS [TIMI-16])

EISSN: 1942-597X ;PMID: 18694141

Full text available

Ankle- and Toe-Brachial Index for Peripheral Artery Disease Identification: Unlocking Clinical Data Through Novel Methods

ISSN: 1941-7640 ;EISSN: 1941-7632 ;DOI: 10.1161/CIRCINTERVENTIONS.121.011092 ;PMID: 35176872

Full text available

Comparison of Transradial Versus Transfemoral Percutaneous Coronary Intervention in Routine Practice: Evidence for the Importance of “Falsification Hypotheses” in Observational Studies of Comparative Effectiveness

2013 American College of Cardiology Foundation ;2015 INIST-CNRS ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.07.036 ;PMID: 23954334 ;CODEN: JACCDI

Full text available

A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices

Mosby, Inc. ;2007 Mosby, Inc. ;2008 INIST-CNRS ;Copyright Elsevier Limited Apr 2007 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2006.12.014 ;PMID: 17383300 ;CODEN: AHJOA2

Full text available

Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology

2008 ;2008 INIST-CNRS ;Copyright Elsevier Limited Jan 2008 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2007.08.022 ;PMID: 18082501 ;CODEN: AHJOA2

Full text available

Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization

Mosby, Inc. ;2010 Mosby, Inc. ;2015 INIST-CNRS ;Copyright 2010 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Jan 2010 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2009.10.023 ;PMID: 20102878 ;CODEN: AHJOA2

Full text available

Trans-ethnic association study of blood pressure determinants in over 750,000 individuals

Copyright Nature Publishing Group Jan 2019 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1061-4036 ;ISSN: 1546-1718 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-018-0303-9 ;PMID: 30578418

Full text available

Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0307-0565 ;EISSN: 1476-5497 ;DOI: 10.1038/s41366-021-00893-4 ;PMID: 34267326

Full text available

Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. 2021 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2021-057632 ;PMID: 34937726

Full text available

Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe

2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 ;ISSN: 0277-0903 ;EISSN: 1532-4303 ;DOI: 10.1080/02770903.2021.2025392

Digital Resources/Online E-Resources